Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?

To: Ian@SI who wrote (950)	7/18/2000 10:29:26 AM
From: michael	Read Replies (1) \| Respond to of 1321

What a buying opportunity. Don't forgot on July 21st.& 22nd. the biggest Bio Investment forum on QLTI and others is coming.

To: Ian@SI who wrote (950)	7/18/2000 5:03:46 PM
From: Stephen O	Read Replies (1) \| Respond to of 1321

People with money will obviously have no problem paying for treatment. It's the unfortunates who require government funding that cause the problem. Perhaps the govt will only ante up $1200 of the $2400 treatment cost. What does that do to the revenue projections. I believe that the analyst has also pooh poohed Miravant product because you would be much more light sensitive. Well if you're going blind you would not mind spending one month indoors watching TV, especially in January or February. If the Miravant product works as well and costs less don't you think the US government would go with the cheaper homegrown version rather than the more expensive Canadian treatment. Just my viewpoint.